Agilent Technologies, Inc. (A) on Decifer

Why it ranks here

• It earns solid returns on the money it puts to work, around 13% and it turns most of its profit into real cash.
• Revenue is growing about 7% a year, profits grew 3% over the past year, and growth is speeding up, not slowing down.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.
• It earns solid returns around 13% and grows revenue about 7% a year, but with no stated reason to grow in our worldview and weak price momentum at 7 out of 35 it stays a middle name.

The current read

The evidence on A lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: Agilent Technologies, Inc. operates in medical - diagnostics & research. That places it inside the Healthcare, Biotech & Devices story.

Read the full A research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.